| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| REGN | REGENERON PHARMACEUTICALS, INC. | Landry Robert E | EVP Finance CFO | Feb 02, 2024 | Option Exercise | $617.34 | 681 | 420,411 | 23,974 | Feb 06, 2024, 04:08 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | Landry Robert E | EVP Finance CFO | Jan 31, 2024 | Option Exercise | $616.51 | 682 | 420,456 | 23,856 | Feb 02, 2024, 04:02 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | Landry Robert E | EVP Finance CFO | Jan 23, 2024 | Option Exercise | $614.56 | 1,876 | 1,152,914 | 24,084 | Jan 25, 2024, 04:17 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | Landry Robert E | EVP Finance CFO | Jan 24, 2024 | Option Exercise | $615.41 | 852 | 524,334 | 23,808 | Jan 25, 2024, 04:17 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | Landry Robert E | EVP Finance CFO | Jan 17, 2024 | Option Exercise | $608.36 | 854 | 519,538 | 23,338 | Jan 18, 2024, 04:02 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | Landry Robert E | EVP Finance CFO | Jan 12, 2024 | Option Exercise | $607.01 | 1,368 | 830,390 | 23,406 | Jan 17, 2024, 04:03 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | Landry Robert E | EVP Finance CFO | Jan 04, 2024 | Option Exercise | $597.53 | 842 | 503,121 | 22,948 | Jan 08, 2024, 04:02 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | Landry Robert E | EVP Finance CFO | Dec 27, 2023 | Option Exercise | $585.89 | 1,292 | 756,973 | 22,111 | Dec 29, 2023, 04:05 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | Landry Robert E | EVP Finance CFO | Dec 28, 2023 | Option Exercise | $590.75 | 1,462 | 863,680 | 22,419 | Dec 29, 2023, 04:05 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | Landry Robert E | EVP Finance CFO | Dec 12, 2023 | Option Exercise | $856.71 | 6,381 | 5,466,667 | 21,084 | Dec 14, 2023, 04:08 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | Landry Robert E | EVP Finance CFO | Dec 13, 2023 | Option Exercise | $585.49 | 1,723 | 1,008,800 | 22,084 | Dec 14, 2023, 04:08 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | Landry Robert E | EVP Finance CFO | Dec 08, 2023 | Option Exercise | $843.79 | 1,013 | 854,759 | 30,686 | Dec 12, 2023, 04:01 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | Landry Robert E | EVP Finance CFO | Dec 11, 2023 | Option Exercise | $844.09 | 3,221 | 2,718,814 | 30,017 | Dec 12, 2023, 04:01 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | Landry Robert E | EVP Finance CFO | Aug 23, 2023 | Sale | $844.00 | 223 | 188,212 | 31,699 | Aug 25, 2023, 04:02 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | Landry Robert E | EVP Finance CFO | Mar 28, 2023 | Sale | $823.47 | 1,007 | 829,233 | 32,919 | Mar 29, 2023, 04:07 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | Landry Robert E | EVP Finance CFO | Mar 27, 2023 | Sale | $575.20 | 6,776 | 3,897,548 | 35,316 | Mar 29, 2023, 04:07 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | Landry Robert E | EVP Finance CFO | Feb 03, 2023 | Option Exercise | $576.47 | 5,987 | 3,451,329 | 35,105 | Feb 07, 2023, 04:09 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | Landry Robert E | EVP Finance CFO | Feb 06, 2023 | Sale | $788.88 | 752 | 593,238 | 32,806 | Feb 07, 2023, 04:09 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | Landry Robert E | EVP Finance CFO | Dec 08, 2022 | Option Exercise | $548.08 | 5,261 | 2,883,429 | 31,744 | Dec 12, 2022, 04:34 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | Landry Robert E | EVP Finance CFO | Dec 09, 2022 | Option Exercise | $753.28 | 492 | 370,614 | 28,991 | Dec 12, 2022, 04:34 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | Landry Robert E | EVP Finance CFO | Dec 01, 2022 | Option Exercise | $544.84 | 4,390 | 2,391,861 | 31,244 | Dec 02, 2022, 04:05 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | Landry Robert E | EVP Finance CFO | Dec 02, 2022 | Sale | $756.66 | 610 | 461,564 | 28,772 | Dec 02, 2022, 04:05 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | Landry Robert E | EVP Finance CFO | Oct 31, 2022 | Option Exercise | $541.28 | 3,518 | 1,904,222 | 30,744 | Nov 02, 2022, 04:04 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | Landry Robert E | EVP Finance CFO | Nov 01, 2022 | Sale | $758.06 | 482 | 365,386 | 29,225 | Nov 02, 2022, 04:04 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | Landry Robert E | EVP Finance CFO | Oct 17, 2022 | Sale | $739.50 | 358 | 264,741 | 28,744 | Oct 18, 2022, 04:06 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | Landry Robert E | EVP Finance CFO | Oct 14, 2022 | Option Exercise | $538.33 | 2,642 | 1,422,277 | 30,244 | Oct 18, 2022, 04:06 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | Landry Robert E | EVP Finance CFO | Apr 07, 2022 | Option Exercise | $538.65 | 2,675 | 1,440,896 | 30,244 | Apr 11, 2022, 06:01 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | Landry Robert E | EVP Finance CFO | Apr 08, 2022 | Option Exercise | $542.73 | 14,463 | 7,849,477 | 34,744 | Apr 11, 2022, 06:01 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | Landry Robert E | EVP Finance CFO | Apr 11, 2022 | Sale | $734.06 | 1,862 | 1,366,821 | 30,532 | Apr 11, 2022, 06:01 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | Landry Robert E | EVP Finance CFO | Mar 31, 2022 | Option Exercise | $532.59 | 2,684 | 1,429,462 | 30,244 | Apr 01, 2022, 04:07 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | Landry Robert E | EVP Finance CFO | Apr 01, 2022 | Sale | $695.81 | 316 | 219,875 | 28,759 | Apr 01, 2022, 04:07 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | Landry Robert E | EVP Finance CFO | Mar 28, 2022 | Option Exercise | $542.72 | 26,317 | 14,282,813 | 34,293 | Mar 30, 2022, 04:42 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | Landry Robert E | EVP Finance CFO | Mar 29, 2022 | Sale | $687.90 | 2,683 | 1,845,630 | 31,373 | Mar 30, 2022, 04:42 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | Landry Robert E | EVP Finance CFO | Mar 21, 2022 | Sale | $569.52 | 1,012 | 576,357 | 29,056 | Mar 23, 2022, 04:02 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | Landry Robert E | EVP Finance CFO | Mar 16, 2022 | Sale | $677.00 | 300 | 203,100 | 28,960 | Mar 18, 2022, 04:08 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | Landry Robert E | EVP Finance CFO | Mar 17, 2022 | Option Exercise | $533.42 | 734 | 391,534 | 29,242 | Mar 18, 2022, 04:08 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | Landry Robert E | EVP Finance CFO | Dec 10, 2021 | Option Exercise | $607.82 | 2,884 | 1,752,952 | 31,457 | Dec 14, 2021, 04:03 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | Landry Robert E | EVP Finance CFO | Dec 11, 2021 | Option Exercise | $664.34 | 697 | 463,045 | 29,376 | Dec 14, 2021, 04:03 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | Landry Robert E | EVP Finance CFO | Dec 13, 2021 | Sale | $662.50 | 116 | 76,850 | 29,260 | Dec 14, 2021, 04:03 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | Landry Robert E | EVP Finance CFO | Dec 09, 2021 | Option Exercise | $515.36 | 7,719 | 3,978,070 | 34,207 | Dec 10, 2021, 05:37 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | Landry Robert E | EVP Finance CFO | Dec 10, 2021 | Sale | $666.42 | 781 | 520,477 | 30,736 | Dec 10, 2021, 05:37 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | Landry Robert E | EVP Finance CFO | Nov 16, 2021 | Option Exercise | $513.22 | 6,819 | 3,499,621 | 29,736 | Nov 18, 2021, 04:23 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | Landry Robert E | EVP Finance CFO | Nov 17, 2021 | Sale | $645.08 | 681 | 439,299 | 25,986 | Nov 18, 2021, 04:23 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | Landry Robert E | EVP Finance CFO | Aug 31, 2021 | Option Exercise | $612.77 | 1,917 | 1,174,673 | 26,903 | Sep 01, 2021, 04:05 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | Landry Robert E | EVP Finance CFO | Aug 06, 2021 | Option Exercise | $483.42 | 3,636 | 1,757,726 | 27,903 | Aug 10, 2021, 05:55 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | Landry Robert E | EVP Finance CFO | Aug 09, 2021 | Option Exercise | $496.31 | 5,827 | 2,891,997 | 28,903 | Aug 10, 2021, 05:55 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | Landry Robert E | EVP Finance CFO | Aug 10, 2021 | Sale | $611.90 | 537 | 328,593 | 26,007 | Aug 10, 2021, 05:55 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | Landry Robert E | EVP Finance CFO | Aug 04, 2020 | Sale | $654.46 | 696 | 455,504 | 23,973 | Aug 05, 2020, 05:07 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | Landry Robert E | EVP Finance CFO | Jul 20, 2020 | Option Exercise | $567.89 | 15,913 | 9,036,900 | 29,671 | Jul 22, 2020, 04:30 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | Landry Robert E | EVP Finance CFO | Jul 21, 2020 | Sale | $647.58 | 391 | 253,204 | 24,672 | Jul 22, 2020, 04:30 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | Landry Robert E | EVP Finance CFO | Jul 14, 2020 | Sale | $640.50 | 579 | 370,850 | 23,973 | Jul 14, 2020, 04:17 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | Landry Robert E | EVP Finance CFO | Jul 09, 2020 | Option Exercise | $508.09 | 5,421 | 2,754,376 | 26,973 | Jul 13, 2020, 04:28 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | Landry Robert E | EVP Finance CFO | Jul 07, 2020 | Option Exercise | $579.84 | 23,840 | 13,823,429 | 33,973 | Jul 09, 2020, 04:29 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | Landry Robert E | EVP Finance CFO | Jul 08, 2020 | Sale | $639.66 | 1,160 | 742,011 | 25,109 | Jul 09, 2020, 04:29 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | Landry Robert E | EVP Finance CFO | Jun 29, 2020 | Sale | $612.57 | 400 | 245,029 | 24,334 | Jun 30, 2020, 04:02 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | Landry Robert E | EVP Finance CFO | Jun 22, 2020 | Option Exercise | $589.89 | 17,288 | 10,197,945 | 33,273 | Jun 24, 2020, 04:03 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | Landry Robert E | EVP Finance CFO | Jun 23, 2020 | Sale | $631.27 | 512 | 323,212 | 24,845 | Jun 24, 2020, 04:03 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | Landry Robert E | EVP Finance CFO | Jun 10, 2020 | Option Exercise | $413.71 | 6,012 | 2,487,222 | 27,873 | Jun 12, 2020, 04:01 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | Landry Robert E | EVP Finance CFO | Jun 11, 2020 | Sale | $612.08 | 988 | 604,731 | 24,916 | Jun 12, 2020, 04:01 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | Landry Robert E | EVP Finance CFO | Jun 08, 2020 | Option Exercise | $407.02 | 26,729 | 10,879,192 | 29,860 | Jun 10, 2020, 04:04 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | Landry Robert E | EVP Finance CFO | Jun 09, 2020 | Sale | $608.01 | 4,271 | 2,596,792 | 28,534 | Jun 10, 2020, 04:04 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | Landry Robert E | EVP Finance CFO | Apr 17, 2020 | Option Exercise | $400.28 | 22,741 | 9,102,747 | 36,873 | Apr 20, 2020, 07:29 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | Landry Robert E | EVP Finance CFO | Apr 20, 2020 | Sale | $566.94 | 3,250 | 1,842,539 | 27,588 | Apr 20, 2020, 07:29 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | Landry Robert E | EVP Finance CFO | Apr 16, 2020 | Option Exercise | $383.07 | 7,009 | 2,684,938 | 28,373 | Apr 20, 2020, 07:29 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | Landry Robert E | EVP Finance CFO | Apr 14, 2020 | Option Exercise | $379.82 | 6,147 | 2,334,728 | 27,873 | Apr 16, 2020, 04:03 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | Landry Robert E | EVP Finance CFO | Apr 15, 2020 | Sale | $518.49 | 853 | 442,276 | 25,172 | Apr 16, 2020, 04:03 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | Landry Robert E | EVP Finance CFO | Apr 09, 2020 | Option Exercise | $374.67 | 6,172 | 2,312,494 | 27,873 | Apr 13, 2020, 07:23 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | Landry Robert E | EVP Finance CFO | Apr 13, 2020 | Sale | $509.79 | 828 | 422,108 | 25,102 | Apr 13, 2020, 07:23 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | Landry Robert E | EVP Finance CFO | Apr 06, 2020 | Option Exercise | $371.41 | 5,304 | 1,969,985 | 27,373 | Apr 08, 2020, 04:02 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | Landry Robert E | EVP Finance CFO | Apr 07, 2020 | Sale | $497.52 | 696 | 346,271 | 24,375 | Apr 08, 2020, 04:02 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | Landry Robert E | EVP Finance CFO | Apr 02, 2020 | Sale | $495.88 | 105 | 52,068 | 25,092 | Apr 03, 2020, 04:50 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | Landry Robert E | EVP Finance CFO | Apr 03, 2020 | Sale | $494.28 | 683 | 337,592 | 24,935 | Apr 03, 2020, 04:50 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | Landry Robert E | EVP Finance CFO | Apr 02, 2020 | Sale | $391.30 | 6,565 | 2,568,852 | 28,726 | Apr 03, 2020, 04:49 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | Landry Robert E | EVP Finance CFO | Apr 01, 2020 | Option Exercise | $373.23 | 11,247 | 4,197,746 | 26,937 | Apr 03, 2020, 04:49 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | Landry Robert E | EVP Finance CFO | Feb 24, 2020 | Option Exercise | $331.62 | 1,786 | 592,280 | 25,973 | Feb 26, 2020, 06:14 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | Landry Robert E | EVP Finance CFO | Feb 25, 2020 | Sale | $360.79 | 2,014 | 726,628 | 26,187 | Feb 26, 2020, 06:14 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | Landry Robert E | EVP Finance CFO | Feb 26, 2020 | Sale | $456.21 | 200 | 91,242 | 25,163 | Feb 26, 2020, 06:14 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | Landry Robert E | EVP Finance CFO | Feb 12, 2020 | Option Exercise | $329.75 | 893 | 294,470 | 25,473 | Feb 14, 2020, 04:10 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | Landry Robert E | EVP Finance CFO | Feb 13, 2020 | Sale | $400.05 | 107 | 42,806 | 25,033 | Feb 14, 2020, 04:10 PM | |
| REGN | REGENERON PHARMACEUTICALS INC | Landry Robert E | SVP Finance & CFO | Sep 01, 2017 | Option Exercise | $372.80 | 5,337 | 1,989,615 | 10,099 | Sep 06, 2017, 05:06 PM | |
| REGN | REGENERON PHARMACEUTICALS INC | Landry Robert E | SVP Finance & CFO | Sep 05, 2017 | Sale | $501.06 | 189 | 94,700 | 7,662 | Sep 06, 2017, 05:06 PM | |
| REGN | REGENERON PHARMACEUTICALS INC | Landry Robert E | SVP Finance & CFO | Sep 06, 2017 | Sale | $497.62 | 474 | 235,873 | 7,473 | Sep 06, 2017, 05:06 PM | |
| REGN | REGENERON PHARMACEUTICALS INC | Landry Robert E | SVP Finance & CFO | Aug 30, 2017 | Option Exercise | $367.01 | 3,573 | 1,311,309 | 9,099 | Sep 01, 2017, 04:04 PM | |
| REGN | REGENERON PHARMACEUTICALS INC | Landry Robert E | SVP Finance & CFO | Aug 31, 2017 | Sale | $493.43 | 427 | 210,693 | 7,426 | Sep 01, 2017, 04:04 PM | |
| REGN | REGENERON PHARMACEUTICALS INC | Landry Robert E | SVP Finance & CFO | Aug 22, 2017 | Option Exercise | $360.92 | 3,532 | 1,274,785 | 9,099 | Aug 24, 2017, 04:47 PM | |
| REGN | REGENERON PHARMACEUTICALS INC | Landry Robert E | SVP Finance & CFO | Aug 23, 2017 | Sale | $476.45 | 468 | 222,981 | 7,467 | Aug 24, 2017, 04:47 PM | |
| REGN | REGENERON PHARMACEUTICALS INC | Landry Robert E | SVP Finance & CFO | Aug 07, 2017 | Option Exercise | $355.13 | 3,474 | 1,233,729 | 9,099 | Aug 09, 2017, 04:03 PM | |
| REGN | REGENERON PHARMACEUTICALS INC | Landry Robert E | SVP Finance & CFO | Aug 08, 2017 | Sale | $472.19 | 526 | 248,372 | 7,525 | Aug 09, 2017, 04:03 PM | |
| REGN | REGENERON PHARMACEUTICALS INC | Landry Robert E | SVP Finance & CFO | Aug 05, 2015 | Sale | $432.77 | 8,000 | 3,462,150 | 11,099 | Aug 06, 2015, 09:00 PM | |
| REGN | REGENERON PHARMACEUTICALS INC | Landry Robert E | SVP Finance & CFO | Apr 08, 2015 | Option Exercise | $350.73 | 17,901 | 6,278,500 | 15,000 | Apr 09, 2015, 04:03 PM |
Menu